Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA

Ian E. Krop(Dana-Farber Cancer Institute), Nancy U. Lin(Dana-Farber Cancer Institute), Kimberly Blackwell(Duke Medical Center), Ellie Guardino, Jens Huober(University of St. Gallen), Mengdi Lu, David Miles(Mount Vernon Cancer Centre), Meghna Samant, Manfred Welslau(Klinikum Aschaffenburg), Véronique Dièras(Institut Curie)
Annals of Oncology
October 30, 2014
10.1093/annonc/mdu486
Cited by 401Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis